Swiss pharma industry fights lower drug prices in the US
The American subsidiaries of Swiss drug giants, Roche and Novartis, have actively participated in the lobbying of US Congress members over the proposal to lower drug prices in the US. Copyright 2017 The Associated Press. All Rights Reserved.
A proposed law currently under discussion in the United States Congress aims to lower prescription drug prices. But Big Pharma, including Swiss giants Roche and Novartis, are pulling out all the stops to lobby against the measure.
This content was published on May 24, 2021 - 10:11
May 24, 2021 - 10:11
Alexis Rapin, Montréal
The issue often sparks heated debate across the Atlantic. The cost of prescription drugs in the US is among the highest in the world, with many Americans regularly forced to bleed themselves dry just to pay their pharmaceutical bills. Written in 2019 and dusted off last April, draft legislation to reform the law is currently being discussed by Congress. It’s a m
To end the pandemic, do we need stricter international health security rules?â¯
Assembly hall of the World Health Organization s (WHO) in Geneva Keystone / Salvatore Di Nolfi
Most countriesâ¯were unprepared for the COVID-19 pandemic and only sporadically implemented World Health Organization (WHO) recommendations. As the virus risks becoming endemic, what are the next steps? Some world leaders and the WHO have suggested an international pandemic treaty. Experts and the WHO disagree on whether the approach is realistic.
This content was published on May 18, 2021 - 17:45
May 18, 2021 - 17:45
Akiko Uehara
Born in Yokohama, Japan. I live in Switzerland since 1999. I hold a masterâs degree in international relations from Geneva. I am the Head of the Japanese section of swissinfo.ch since 2016. Previously, I worked for 15 years for Asahi Shimbun at the UN in Geneva, where I closely followed multilateral and Swiss affairs. I was secretary-general of the Foreign Press Ass
WEF cancels 2021 annual meeting in Singapore
WEF founder Klaus Schwab says the decision to postpone the annual meeting was difficult . Keystone / Laurent Gillieron
The World Economic Forum (WEF) has been forced to cancel its flagship annual meeting that was due to be staged in Singapore this summer.
This content was published on May 17, 2021 - 16:43
May 17, 2021 - 16:43
swissinfo.ch/mga
Singapore has recently seen an escalation in the number of coronavirus infections, forcing the island state to take further measures to prevent its spread. WEF had originally arranged to move its annual meeting from the Swiss mountain resort of Davos to Singapore for this month, before postponing the event until August.